AERIE PHARMACEUTICALS INC - COM (AERI)

CUSIP: 00771V108

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
47,290,010
Share change
+926,780
Total reported value
$332,084,902
Put/Call ratio
21%
Price per share
$7.02
Number of holders
126
Value change
-$7,111,865
Number of buys
62
Number of sells
74

Quarterly Holders Quick Answers

What is CUSIP 00771V108?
CUSIP 00771V108 identifies AERI - AERIE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q4 2021

As of 31 Dec 2021, AERIE PHARMACEUTICALS INC - COM (AERI) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,290,010 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MORGAN STANLEY, BlackRock Inc., VANGUARD GROUP INC, Jefferies Group LLC, BANK OF AMERICA CORP /DE/, AMERIPRISE FINANCIAL INC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SCHRODER INVESTMENT MANAGEMENT GROUP, and Granahan Investment Management, LLC. This page lists 126 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.